1. Secondary Prevention of Acute Ischemic Stroke: Can We Improve Outcomes?

2. Panelists

3. Program Goals

4. Scope of the Problem Number of Strokes Annually

5. Hemorrhagic vs. Ischemic Stroke

6. Types of Stroke US Distribution

7. Stroke Recurrence

8. Standard of Care Acute Ischemic Stroke Intravenous Thrombolysis

10. Paradigm Shift IV Thrombolysis for Ischemic Stroke

12. Guidelines for the Management of Hypertension in Patients With Ischemic Stroke/TIA

14. Guidelines for Lipid Management in Patients With Ischemic Stroke/TIA

16. Antiplatelets for Secondary Prevention After TIA or Ischemic Stroke

17. Completed Antiplatelet Trials

18. Risk Reduction for Recurrent Stroke Associated With Antiplatelet Therapy

19. What’s New?

20. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

21. Triple Antiplatelets for Reducing Dependency After Ischemic Stroke (TARDIS)

22. SOCRATES

23. Limitations to IV Thrombolysis

24. Thrombectomy Trials

25. Pre-Hospital Stroke Evaluation

27. Neuroprotectants?

28. Public Education

29. Review of Antiplatelet Recommendations in US and Europe

30. Concluding Comments

31. Abbreviations

32. Abbreviations (cont)